Reported 0 shares, down 921,330 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 6999000 |
| 2022-03-31 | 7379000 |
| 2022-06-30 | 8896000 |
| 2022-09-30 | 5369000 |
| 2022-12-31 | 5832000 |
| 2023-03-31 | 25716000 |
| 2023-06-30 | 15811734 |
| 2023-09-30 | 2138154 |
| 2023-12-31 | 21761815 |
| 2024-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2024 | Reduced | 0 | -921,330 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | Added | 921,330 | +777,926 (542.5%) | < 0.01% | $21,761,815 | 2024-02-14 | |
| Q3 2023 | Reduced | 143,404 | -1,300,590 (-90.1%) | < 0.01% | $2,138,154 | 2023-11-14 | |
| Q2 2023 | Reduced | 1,443,994 | -1,505,062 (-51.0%) | < 0.01% | $15,811,734 | 2023-08-14 | |
| Q1 2023 | Added | 2,949,056 | +2,018,868 (217.0%) | 0.01% | $25,716,000 | 2023-05-15 | |
| Q4 2022 | Reduced | 930,188 | -603,794 (-39.4%) | < 0.01% | $5,832,000 | 2023-02-14 | |
| Q3 2022 | Reduced | 1,533,982 | -1,481,514 (-49.1%) | < 0.01% | $5,369,000 | 2022-11-14 | |
| Q2 2022 | Added | 3,015,496 | +642,796 (27.1%) | < 0.01% | $8,896,000 | 2022-08-15 | |
| Q1 2022 | Added | 2,372,700 | +301,913 (14.6%) | < 0.01% | $7,379,000 | 2022-05-16 | |
| Q4 2021 | Added | 2,070,787 | +112,134 (5.7%) | < 0.01% | $6,999,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
200 managers reported CYMABAY THERAPEUTICS INC for Q1 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Unchanged | 650 | 0 | < 0.01% | $21,077 | 19 qtrs |
| GREAT WEST LIFE ASSURANCE CO CAN | Reduced | 0 | -8,424 | 0 | $0 | 5 qtrs |
| VICTORY CAPITAL MANAGEMENT INC | Reduced | 0 | -689,603 | 0 | $0 | 5 qtrs |
| Hennion & Walsh Asset Management Inc | Reduced | 0 | -78,311 | 0 | $0 | 4 qtrs |
| Metropolitan Life Insurance Co NY | Reduced | 0 | -6,447 | 0 | $0 | 4 qtrs |
| Novo Holdings A S | Reduced | 0 | -900,000 | 0 | $0 | 4 qtrs |
| J Goldman & Co LP | Reduced | 0 | -165,937 | 0 | $0 | 3 qtrs |
| Harvest Fund Management Co Ltd | Reduced | 0 | -1,076 | 0 | $0 | 2 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 0 | -68,457 | 0 | $0 | 20 qtrs |
| AMERIPRISE FINANCIAL INC | Reduced | 0 | -25,711 | 0 | $0 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2024
- Filed
- May 15, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.